REAL Real Matters

Real Matters Reports Second Quarter Financial Results

Real Matters Inc. (TSX: REAL) (“Real Matters” or the “Company”), a leading network management services platform for the mortgage and insurance industries, today announced its financial results for the second quarter ended March 31, 2024.

“We were very pleased to report positive consolidated Adjusted EBITDA(A) of $0.7 million and net income of $2.1 million in the second quarter as we outperformed the market on a sequential and year-over-year basis in U.S. Appraisal principally due to market share gains,” said Real Matters Chief Executive Officer Brian Lang. “Consolidated revenues were up 19% quarter-over-quarter due to a 22% increase in U.S. Appraisal revenues and a 15% increase in Canadian segment revenues. U.S. Title revenues were flat quarter-over-quarter.”

“Through our network management model, we continued to improve U.S. Appraisal Net Revenue(A) margins which set a new record high of 28.3%, up 40 basis points from the first quarter. We also had strong operating leverage in the second quarter, particularly in our U.S. Appraisal segment where Adjusted EBITDA(A) margins increased 1,210 basis points quarter-over-quarter to 47.9%,” added Lang.

“While the mortgage market continues to face interest rate and affordability headwinds, our business model, focus on market share, and operating efficiency are delivering improved financial performance. We are well-positioned for growth when market conditions improve and the business scales back up,” concluded Lang.

Q2 2024 Highlights

  • Consolidated revenues of $42.2 million, up 19% quarter-over-quarter
  • Positive consolidated Adjusted EBITDA(A) of $0.7 million and net income of $2.1 million
  • Record-high U.S. Appraisal Net Revenue(A) margins of 28.3%, up 40 basis points quarter-over-quarter and up 70 basis points year-over-year
  • Year-over-year market share gains with 4 of our top 7 U.S. Appraisal clients
  • Quarter-over-quarter market share gains with Tier 1 lender and launched 2 new clients in U.S. Title
  • Year-over-year market share gains with 2 top clients and launched 2 new clients and 1 new channel in Canada
  • Cash and cash equivalents of $44.4 million and no outstanding debt

Financial and Operational Summary

(millions of dollars)

 

Quarter ended

 

 

 

 

Six months ended

 

%

 

 

2024

 

 

2024

 

 

2023

 

 

2023

 

 

2023

 

% Change

 

 

2024

 

 

2023

 

Change

 

 

Q2

 

 

Q1

 

 

Q4

 

 

Q3

 

 

Q2

 

Quarter

over

Quarter

 

Year

over

Year

 

March 31

 

March 31

 

Year

over

Year

Consolidated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

$

42.2

 

$

35.4

 

$

42.2

 

$

46.0

 

$

37.6

 

19%

 

12%

 

$

77.6

 

$

75.8

 

2%

Net Revenue(A)

$

11.5

 

$

9.7

 

$

11.2

 

$

12.1

 

$

9.9

 

19%

 

16%

 

$

21.2

 

$

19.7

 

8%

Adjusted EBITDA(A)

$

0.7

 

$

(1.1)

 

$

0.6

 

$

1.7

 

$

(1.7)

 

166%

 

142%

 

$

(0.4)

 

$

(4.6)

 

92%

Net income (loss)

$

2.1

 

$

(3.6)

 

$

1.6

 

$

(0.6)

 

$

(2.6)

 

158%

 

181%

 

$

(1.5)

 

$

(7.2)

 

79%

Net income (loss) per diluted share

$

0.03

 

$

(0.05)

 

$

0.02

 

$

(0.01)

 

$

(0.04)

 

160%

 

175%

 

$

(0.02)

 

$

(0.10)

 

80%

Adjusted Net income (loss)(A)

$

1.3

 

$

(1.2)

 

$

0.8

 

$

1.0

 

$

(1.9)

 

207%

 

168%

 

$

0.1

 

$

(4.0)

 

103%

Adjusted Net income (loss)(A) per diluted share

$

0.02

 

$

(0.02)

 

$

0.01

 

$

0.01

 

$

(0.03)

 

200%

 

167%

 

$

-

 

$

(0.06)

 

100%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Appraisal segment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

$

32.6

 

$

26.8

 

$

31.2

 

$

33.5

 

$

28.0

 

22%

 

16%

 

$

59.3

 

$

56.3

 

6%

Net Revenue(A)

$

9.2

 

$

7.5

 

$

8.6

 

$

9.2

 

$

7.7

 

23%

 

19%

 

$

16.6

 

$

15.4

 

9%

Net Revenue(A) margin

 

28.3%

 

 

27.9%

 

 

27.5%

 

 

27.5%

 

 

27.6%

 

 

 

 

 

 

28.1%

 

 

27.3%

 

 

Adjusted EBITDA(A)

$

4.4

 

$

2.7

 

$

3.9

 

$

4.8

 

$

3.1

 

65%

 

40%

 

$

7.1

 

$

5.5

 

30%

Adjusted EBITDA(A) margin

 

47.9%

 

 

35.8%

 

 

46.0%

 

 

52.0%

 

 

40.6%

 

 

 

 

 

 

42.5%

 

 

35.5%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Title segment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

$

2.0

 

$

2.0

 

$

2.3

 

$

2.6

 

$

2.2

 

0%

 

-9%

 

$

4.1

 

$

4.6

 

-11%

Net Revenue(A)

$

0.9

 

$

1.0

 

$

1.0

 

$

1.2

 

$

0.8

 

-7%

 

9%

 

$

1.9

 

$

1.6

 

13%

Net Revenue(A) margin

 

44.0%

 

 

47.3%

 

 

45.0%

 

 

45.2%

 

 

36.8%

 

 

 

 

 

 

45.7%

 

 

35.7%

 

 

Adjusted EBITDA(A)

$

(1.7)

 

$

(1.6)

 

$

(1.6)

 

$

(1.6)

 

$

(2.3)

 

-2%

 

28%

 

$

(3.3)

 

$

(5.2)

 

37%

Adjusted EBITDA(A) margin

 

-184.8%

 

 

-167.9%

 

 

-150.4%

 

 

-133.6%

 

 

-279.3%

 

 

 

 

 

 

-176.0%

 

 

-316.4%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Canadian segment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

$

7.6

 

$

6.6

 

$

8.7

 

$

9.9

 

$

7.4

 

15%

 

2%

 

$

14.2

 

$

14.9

 

-5%

Net Revenue(A)

$

1.4

 

$

1.2

 

$

1.6

 

$

1.7

 

$

1.4

 

15%

 

3%

 

$

2.7

 

$

2.7

 

-2%

Net Revenue(A) margin

 

18.9%

 

 

18.8%

 

 

17.9%

 

 

17.6%

 

 

18.7%

 

 

 

 

 

 

18.8%

 

 

18.3%

 

 

Adjusted EBITDA(A)

$

0.9

 

$

0.7

 

$

1.2

 

$

1.3

 

$

1.0

 

26%

 

-8%

 

$

1.6

 

$

1.8

 

-13%

Adjusted EBITDA(A) margin

 

62.3%

 

 

56.8%

 

 

72.9%

 

 

73.7%

 

 

69.8%

 

 

 

 

 

 

59.7%

 

 

67.0%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate segment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA(A)

$

(2.9)

 

$

(2.9)

 

$

(2.9)

 

$

(2.8)

 

$

(3.5)

 

-4%

 

16%

 

$

(5.8)

 

$

(6.7)

 

14%

Conference Call and Webcast

A conference call to review the results will take place at 10:00 a.m. (ET) on Tuesday, May 7, 2024, hosted by Chief Executive Officer Brian Lang and Chief Financial Officer Rodrigo Pinto. An accompanying slide presentation will be posted to the Investor section of our website shortly before the call.

To access the call:

  • Participant Local (Toronto): (416) 764-8624
  • Participant Toll Free Dial-In Number: (888) 259-6580
  • Conference ID: 15967181

To listen to the live webcast of the call:

  • Go to:

The webcast will be archived and a transcript of the call will be available in the Investor section of our website following the call.

(A) Non-GAAP Measures

The non-GAAP measures used in this news release, including Net Revenue, Adjusted EBITDA and Adjusted Net Income do not have a standardized meaning prescribed by International Financial Reporting Standards and are therefore unlikely to be comparable to similar measures presented by other issuers. These non-GAAP measures are more fully defined and discussed in the Company’s MD&A for the three and six months ended March 31, 2024 under the heading “Non-GAAP measures”, which is incorporated by reference in this Press Release and available on SEDAR+ at .

Real Matters financial results for the three and six months ended March 31, 2024 are included in the unaudited interim condensed consolidated financial statements and the accompanying MD&A, each of which are available on SEDAR+ at . In addition, supplemental information is available on our website at .

Net Revenue represents the difference between revenues and transaction costs. Net Revenue margin is calculated as Net Revenue divided by Revenues. The reconciling items between net income or loss and Net Revenue were as follows:

 

 

 

 

 

 

 

 

Quarter ended

 

Six months ended

 

 

Q2 2024

 

 

Q1 2024

 

 

Q4 2023

 

 

Q3 2023

 

 

Q2 2023

 

March 31,

2024

 

March 31,

2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

$

2.1

 

$

(3.6)

 

$

1.6

 

$

(0.6)

 

$

(2.6)

 

$

(1.5)

 

$

(7.2)

Operating expenses

 

11.2

 

 

11.6

 

 

10.9

 

 

10.7

 

 

11.9

 

 

22.8

 

 

25.1

Amortization

 

0.8

 

 

0.8

 

 

0.9

 

 

1.0

 

 

1.0

 

 

1.6

 

 

2.0

Restructuring expenses

 

-

 

 

-

 

 

-

 

 

-

 

 

0.4

 

 

-

 

 

1.7

Interest expense

 

0.1

 

 

0.1

 

 

0.1

 

 

0.1

 

 

0.1

 

 

0.2

 

 

0.2

Interest income

 

(0.4)

 

 

(0.4)

 

 

(0.3)

 

 

(0.2)

 

 

(0.2)

 

 

(0.8)

 

 

(0.3)

Net foreign exchange (gain) loss

 

(2.2)

 

 

2.0

 

 

(1.8)

 

 

1.8

 

 

0.1

 

 

(0.2)

 

 

1.1

Loss (gain) on fair value of derivatives

 

0.1

 

 

(0.2)

 

 

(0.1)

 

 

(0.5)

 

 

(0.3)

 

 

(0.1)

 

 

(0.3)

Income tax recovery

 

(0.2)

 

 

(0.6)

 

 

(0.1)

 

 

(0.2)

 

 

(0.5)

 

 

(0.8)

 

 

(2.6)

Net Revenue

$

11.5

 

$

9.7

 

$

11.2

 

$

12.1

 

$

9.9

 

$

21.2

 

$

19.7

Adjusted EBITDA represents net income or loss before stock-based compensation expense, amortization, restructuring expenses, interest expense, interest income, net foreign exchange gain or loss, gain or loss on fair value of derivatives and income tax expense or recovery. Adjusted EBITDA margin is calculated as Adjusted EBITDA divided by Net Revenue. The reconciling items between net income or loss and Adjusted EBITDA were as follows:

 

 

 

 

 

 

 

 

Quarter ended

 

Six months ended

 

 

Q2 2024

 

 

Q1 2024

 

 

Q4 2023

 

 

Q3 2023

 

 

Q2 2023

 

March 31, 2024

 

March 31, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

$

2.1

 

$

(3.6)

 

$

1.6

 

$

(0.6)

 

$

(2.6)

 

$

(1.5)

 

$

(7.2)

Stock-based compensation expense

 

0.4

 

 

0.8

 

 

0.3

 

 

0.3

 

 

0.3

 

 

1.2

 

 

0.8

Amortization

 

0.8

 

 

0.8

 

 

0.9

 

 

1.0

 

 

1.0

 

 

1.6

 

 

2.0

Restructuring expenses

 

-

 

 

-

 

 

-

 

 

-

 

 

0.4

 

 

-

 

 

1.7

Interest expense

 

0.1

 

 

0.1

 

 

0.1

 

 

0.1

 

 

0.1

 

 

0.2

 

 

0.2

Interest income

 

(0.4)

 

 

(0.4)

 

 

(0.3)

 

 

(0.2)

 

 

(0.2)

 

 

(0.8)

 

 

(0.3)

Net foreign exchange (gain) loss

 

(2.2)

 

 

2.0

 

 

(1.8)

 

 

1.8

 

 

0.1

 

 

(0.2)

 

 

1.1

Loss (gain) on fair value of derivatives

 

0.1

 

 

(0.2)

 

 

(0.1)

 

 

(0.5)

 

 

(0.3)

 

 

(0.1)

 

 

(0.3)

Income tax recovery

 

(0.2)

 

 

(0.6)

 

 

(0.1)

 

 

(0.2)

 

 

(0.5)

 

 

(0.8)

 

 

(2.6)

Adjusted EBITDA

$

0.7

 

$

(1.1)

 

$

0.6

 

$

1.7

 

$

(1.7)

 

$

(0.4)

 

$

(4.6)

The reconciling items between net income or loss and Adjusted Net Income or Loss were as follows:

 

 

 

 

 

 

 

 

Quarter ended

 

Six months ended

 

 

Q2 2024

 

 

Q1 2024

 

 

Q4 2023

 

 

Q3 2023

 

 

Q2 2023

 

March 31, 2024

 

March 31, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

$

2.1

 

$

(3.6)

 

$

1.6

 

$

(0.6)

 

$

(2.6)

 

$

(1.5)

 

$

(7.2)

Stock-based compensation expense

 

0.4

 

 

0.8

 

 

0.3

 

 

0.3

 

 

0.3

 

 

1.2

 

 

0.8

Amortization of intangibles

 

0.4

 

 

0.4

 

 

0.4

 

 

0.4

 

 

0.4

 

 

0.8

 

 

0.8

Restructuring expenses

 

-

 

 

-

 

 

-

 

 

-

 

 

0.4

 

 

-

 

 

1.7

Net foreign exchange (gain) loss

 

(2.2)

 

 

2.0

 

 

(1.8)

 

 

1.8

 

 

0.1

 

 

(0.2)

 

 

1.1

Loss (gain) on fair value of derivatives

 

0.1

 

 

(0.2)

 

 

(0.1)

 

 

(0.5)

 

 

(0.3)

 

 

(0.1)

 

 

(0.3)

Related tax effects

 

0.5

 

 

(0.6)

 

 

0.4

 

 

(0.4)

 

 

(0.2)

 

 

(0.1)

 

 

(0.9)

Adjusted Net Income (Loss)

$

1.3

 

$

(1.2)

 

$

0.8

 

$

1.0

 

$

(1.9)

 

$

0.1

 

$

(4.0)

Forward-Looking Information

This Press Release contains “forward-looking information” within the meaning of applicable Canadian securities laws. Words such as “could”, “forecast”, “target”, “may”, “will”, “would”, “expect”, “anticipate”, “estimate”, “intend”, “plan”, “seek”, “believe”, “likely” and “predict” and variations of such words and similar expressions are intended to identify such forward-looking information, although not all forward-looking information contains these identifying words.

The forward-looking information in this Press Release includes statements which reflect the current expectations of management with respect to our business and the industry in which we operate and is based on management’s experience and perception of historical trends, current conditions and expected future developments, as well as other factors that management believes appropriate and reasonable in the circumstances. The forward-looking information reflects management’s beliefs based on information currently available to management, including information obtained from third party sources, and should not be read as a guarantee of the occurrence or timing of any future events, performance or results.

The forward-looking information in this Press Release is subject to risks, uncertainties and other factors that are difficult to predict and that could cause actual results to differ materially from historical results or results anticipated by the forward-looking information. A comprehensive discussion of the factors which could cause results or events to differ from current expectations can be found in the “Risk Factors” section of our Annual Information Form for the year ended September 30, 2023, which is available on SEDAR+ at .

Readers are cautioned not to place undue reliance on the forward-looking information, which reflect our expectations only as of the date of this Press Release. Except as required by law, we do not undertake to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.

About Real Matters

Real Matters is a leading network management services provider for the mortgage lending and insurance industries. Real Matters’ platform combines its proprietary technology and network management capabilities with tens of thousands of independent qualified field professionals to create an efficient marketplace for the provision of mortgage lending and insurance industry services. Our clients include top 100 mortgage lenders in the U.S. and some of the largest banks and insurance companies in Canada. We are a leading independent provider of residential real estate appraisals to the mortgage market and a leading independent provider of title services in the U.S. Headquartered in Markham (ON), Real Matters has principal offices in Buffalo (NY) and Middletown (RI). Real Matters is listed on the Toronto Stock Exchange under the symbol REAL. For more information, visit .

EN
07/05/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Real Matters

Real Matters Inc: 1 director

A director at Real Matters Inc bought 8,000 shares at 5.939CAD and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...

 PRESS RELEASE

Real Matters Reports Second Quarter Financial Results

TORONTO--(BUSINESS WIRE)-- Real Matters Inc. (TSX: REAL) (“Real Matters” or the “Company”), a leading network management services platform for the mortgage and insurance industries, today announced its financial results for the second quarter ended March 31, 2024. “We were very pleased to report positive consolidated Adjusted EBITDA(A) of $0.7 million and net income of $2.1 million in the second quarter as we outperformed the market on a sequential and year-over-year basis in U.S. Appraisal principally due to market share gains,” said Real Matters Chief Executive Officer Brian Lang. “Consoli...

 PRESS RELEASE

Real Matters Announces Changes to its Board of Directors

TORONTO--(BUSINESS WIRE)-- Real Matters Inc. (“Real Matters” or the “Company”), a leading network management services provider for the mortgage lending and insurance industries, today announced that Lisa Melchior will be stepping down after serving on the Real Matters Board since 2017. The Company also announced the appointment of Kay Brekken to its Board of Directors. Ms. Brekken will succeed Ms. Melchior as a member of the Compensation, Nomination and Governance Committee. The changes are effective May 7, 2024. This press release features multimedia. View the full release here: Kay Brekken ...

 PRESS RELEASE

Real Matters to Announce Second Quarter Fiscal 2024 Financial Results ...

TORONTO--(BUSINESS WIRE)-- Real Matters Inc. (“Real Matters”), a leading network management services provider for the mortgage lending and insurance industries, will announce its second quarter fiscal 2024 financial results via news release on Tuesday, May 7, 2024, before market open. Conference Call and Webcast A conference call to review the results will take place at 10:00 a.m. (ET) on Tuesday, May 7, 2024, hosted by Chief Executive Officer Brian Lang and Chief Financial Officer Rodrigo Pinto. An accompanying slide presentation will be posted to the Investor Relations section of our web...

Wedbush Research
  • Wedbush Research
2454 MEDIATEK INC.
MTB M&T BANK CORPORATION
UBI UBISOFT ENTERTAINMENT SA
VMW VMWARE INC. CLASS A
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
WBS WEBSTER FINANCIAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
VLY VALLEY NATIONAL BANCORP
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
TRIP TRIPADVISOR INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
SGMO SANGAMO THERAPEUTICS INC.
RHP RYMAN HOSPITALITY PROPERTIES INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
PZZA PAPA JOHN'S INTERNATIONAL INC.
PSTG PURE STORAGE INC. CLASS A
PEB PEBBLEBROOK HOTEL TRUST
PCRX PACIRA BIOSCIENCES INC.
NYCB NEW YORK COMMUNITY BANCORP INC.
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
KURA KURA ONCOLOGY INC.
KPTI KARYOPHARM THERAPEUTICS
INTC INTEL CORPORATION
GOOGL ALPHABET INC. CLASS A
GLPI GAMING AND LEISURE PROPERTIES INC.
GERN GERON CORP.
FATE FATE THERAPEUTICS INC
EXPE EXPEDIA GROUP INC.
CTMX CYTOMX THERAPEUTICS INC.
CMRX CHIMERIX INC
CFG CITIZENS FINANCIAL GROUP INC.
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BKU BANKUNITED INC.
BIIB BIOGEN INC.
BBY BEST BUY CO. INC.
AXTI AXT INC.
ARDX ARDELYX INC
HST HOST HOTELS & RESORTS INC.
GRBK GREEN BRICK PARTNERS
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
EA ELECTRONIC ARTS INC.
HPE HEWLETT PACKARD ENTERPRISE CO.
UTHR UNITED THERAPEUTICS CORPORATION
CLSD CLEARSIDE BIOMEDICAL INC
ALBO ALBIREO PHARMA
PK PARK HOTELS & RESORTS INC.
REAL REAL MATTERS
ANAB ANAPTYSBIO INC.
KALA KALA PHARMACEUTICALS INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
GTHX G1 THERAPEUTICS
ALPN ALPINE IMMUNE SCIENCES
VRNA VERONA PHARMA ADS
VICI VICI PROPERTIES INC
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
APLS APELLIS PHARMACEUTICALS
BKNG BOOKING HOLDINGS INC.
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
AVGO BROADCOM INC.
ZS ZSCALER INC.
SURF SURFACE ONCOLOGY
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
LQDA LIQUIDIA CORPORATION
REPL REPLIMUNE GROUP
AX AXOS FINANCIAL INC.
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
LYFT LYFT
UBER UBER TECHNOLOGIES INC.
BCEL ATRECA
DELL DELL TECHNOLOGIES INC CLASS C
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
AQST AQUESTIVE THERAPEUTICS
IDYA IDEAYA BIOSCIENCES
PASG PASSAGE BIO
BDTX BLACK DIAMOND THERAPEUTICS
ACET ADICET BIO INC
ITOS ITEOS THERAPEUTICS
ORIC ORIC PHARMACEUTICALS
ZNTL ZENTALIS PHARMACEUTICALS
PRAX PRAXIS PRECISION MEDICINES
U UNITY SOFTWARE
TVTX TRAVERE THERAPEUTICS INC
DASH DOORDASH
ABNB AIRBNB INC. CLASS A
LSEA LANDSEA HOMES CORP (A)
VRDN VIRIDIAN THERAPEUTICS INC
PLTK PLAYTIKA HOLDING
NUVB NUVATION BIO INC (A)
RBLX ROBLOX
DAWN DAY ONE BIOPHARMACEUTICALS INC
ELEV ELEVATION ONCOLOGY
OMGA OMEGA THERAPEUTICS
LBPH LONGBOARD PHARMACEUTICALS
THRX THESEUS PHARMACEUTICALS
MRVL INC.
STX MARVELL TECHNOLOGY INC
APP SEAGATE TECHNOLOGY HLDGS PLC
DSGN APPLOVIN CORP
ATXS DESIGN THERAPEUTICS INC
AVTE ASTRIA THERAPEUTICS INC
GFS AEROVATE THERAPEUTICS INC
RLYB GLOBALFOUNDRIES INC
KRTX RALLYBIO CORP
FUSN KARUNA THERAPEUTICS INC
YOU FUSION PHARMACEUTICALS INC
VIGL CLEAR SECURE INC
MLTX VIGIL NEUROSCIENCE INC
SOUN MOONLAKE IMMUNOTHERAPEUTICS
EWTX SOUNDHOUND AI INC
DDI EDGEWISE THERAPEUTICS INC
SKLZ DOUBLEDOWN INTERACTIVE CO LTD
EMBRAC B SKILLZ INC
EMBRACER GROUP AB

ResearchPool Subscriptions

Get the most out of your insights

Get in touch